CASI: Nilai perusahaan marang bathi resik casipharmaceuticals.com

CASI Pharmaceuticals Inc. - logo grafis emiten CASI

CASI Pharmaceuticals (CASI) enjoys high credibility among physicians due to the development of breakthrough leukemia therapies. The company generates profit from exclusive oncology drug sales in China, ensuring a steady cash flow. The stock's price history demonstrates the value of the -0.10 metric. The business relies on integrating Western licenses into Chinese medicine, remaining dependent on local certification standards.

CASI - Rasio rega marang bathi CASI Pharmaceuticals ing rentang 04.07.2022 - 28.02.2026

Rincian analitis perusahaan CASI Pharmaceuticals

- rega saham lan prakiraan rega para ahli:
Bagan owah-owahan rega CASI Pharmaceuticals, Inc|CASI - Target konsensus
- informasi kapitalisasi pasar:
Nilai pasar CASI Pharmaceuticals, Inc.|CASI - Nilai Perusahaan
- indikator nilai aset resik miturut neraca:
Aset Bersih saben Siji Saham CASI Pharmaceuticals|CASI - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku casipharmaceuticals.com|CASI - Aset Agregat Perusahaan
- informasi babagan utang lan solvabilitas:
Utang marang Modal CASI Pharmaceuticals|CASI - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal CASI Pharmaceuticals, Inc|CASI - Gunggung utang perusahaan|Rasio utang marang nilai buku CASI Pharmaceuticals, Inc.|CASI - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan CASI Pharmaceuticals|Rasio cepet casipharmaceuticals.com
- statistik bathi lan rasio pasar:
CASI - Bathi resik perusahaan|Prakiraan bathi perusahaan CASI Pharmaceuticals|CASI - Pangali P/E|Kapitalisasi marang proyeksi bathi CASI Pharmaceuticals, Inc|CASI - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan CASI Pharmaceuticals, Inc.|CASI - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben siji saham sajrone 12 wulan pungkasan CASI Pharmaceuticals|CASI - Bathi resik saben saham (EPS TTM)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan casipharmaceuticals.com|CASI - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep CASI Pharmaceuticals
Ringkesan analisis perusahaan:casipharmaceuticals.com CASI
Produk asli CASI Pharmaceuticals, Inc.

Investors utilize this ratio as a primary barometer of asset overvaluation, determining the investment payback period through the relationship between market capitalization and net income. The forward P/E dynamics of CASI Pharmaceuticals (CASI) reflect the monetization efficiency of Western onco-hematological developments within the Chinese market, where the ability to rapidly commercialize licensed drugs directly impacts the business's fundamental value.

Pesaing wigati

TGTX: Nilai perusahaan marang bathi resik|Koefisien rega marang bathi ACLX (Arcellx, Inc.)|IRON (Disc Medicine Inc) - Nilai perusahaan marang bathi resik|Pangali P/E SNDX (Syndax)|Kura - Rasio rega marang bathi|ADCT - Rasio rega marang bathi|FHTX: Rasio rega marang bathi|Vor Biopharma (VOR) - Rasio rega marang bathi|Kapitalisasi marang bathi Nkarta (NKTX)|Rasio rega marang bathi Coeptis Therapeutics Inc.|Kapitalisasi marang bathi Actinium Corp ATNM|Pangali P/E ESLA|markertherapeutics.com - Pangali rega marang bathi|Pangali P/E INAB (IN8bio)|ERNA - Koefisien rega marang bathi|GT Biopharma Corp - Pangali P/E|APTO - Pangali P/E|Bio-Path Holdings (BPTH) - Rasio rega marang bathi|MEIP - Periode bali modal bisnis|VINC (Vincerx Pharma Inc.) - Pangali P/E